MedPath

Reflective Testing for Early Diagnosis of Pituitary Dysfunction

Not Applicable
Withdrawn
Conditions
Pituitary Dysfunction
Registration Number
NCT02406417
Lead Sponsor
Nova Scotia Health Authority
Brief Summary

Early detection and management of pituitary dysfunction reduces the morbidity that ensues as a consequence of missed or delayed diagnosis of this condition, and which may result in life-threatening events and increased mortality.

The investigators study will explore the use of reflex strategies within the laboratory in capturing suspicious pituitary function test results from Primary Care patients and following these up with appropriate reflective testing. Subsequently patients identified from these results to have a possible underlying piuitary dysfunction will have an alert sent to their family physician prompting referral to the Endocrine team for further investigation and management.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients from Primary Care found to have one or more abnormal pituitary function test picked up by the laboratory information system in the Clinical Chemistry laboratory.
Exclusion Criteria
  • Patients with known pituitary dysfunction or on medication that may affect pituitary function tests.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of patients found to have biochemical evidence of possible pituitary dysfunctionOne year
Secondary Outcome Measures
NameTimeMethod
Number of patients from primary outcome found to have true pituitary dysfunction6- 12 months

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.